Hk. Guttormsen et al., HUMORAL IMMUNE-RESPONSE TO CLASS-1 OUTER-MEMBRANE PROTEIN DURING THE COURSE OF MENINGOCOCCAL DISEASE, Infection and immunity, 62(4), 1994, pp. 1437-1443
We have determined the amounts of specific anti-class 1 outer membrane
protein antibodies in sera from 25 patients during the course of syst
emic meningococcal disease, using purified class 1 protein as the sens
itizing antigen in an enzyme-linked immunosorbent assay. The class 1 p
rotein was obtained from a variant of strain 44/76 (B:15:P1.7,16) lack
ing class 3 and class 4 outer membrane proteins. Specific anti-class 1
(serosubtype P1.7,16) outer membrane protein immunoglobulin G (IgG) a
ntibody levels increased significantly in 12 patients (12 of 25; 48%),
regardless of the serotype of the infecting strain, indicating that t
he antibodies reacted in part with epitopes not determined by the mono
clonal antibodies used for serotyping. Most patients had low levels of
anti-class 1 IgG antibodies during the acute illness. The antibody le
vels peaked during the second week of disease and returned to near bas
eline levels in sera collected 6 weeks to 12 months after the onset of
the disease. The majority of the specific anti-class 1 IgG antibodies
bound to surface-exposed epitopes on whole bacteria and belonged to t
he IgG1 and IgG3 subclasses. Anti-class 1 IgA and IgM antibodies were
not detected in any of the patient sera. Prior to disease, seven patie
nts had been immunized with a meningococcal outer membrane vesicle vac
cine developed from strain 44/76 (P1.7,16). None of these patients was
infected with meningococcal strains containing class 1 protein homolo
gous or partly homologous to that of the vaccine strain, indicating se
rosubtype-specific protection. The highest anti-class I IgG antibody p
eak levels were seen in immunized patients infected with strains of he
terologous serotype, suggesting an anamnestic response. However, these
patients were not protected from meningococcal disease after immuniza
tion.